Many factors helped columnist Sam Kirton know when it was time to stop working so he could better attend to his health issues with IPF.

Nerandomilast demonstrated it was able to outperform a placebo at improving lung function in IPF or preventing its decline ...

As his birthday approaches, columnist Sam Kirton shares what has transpired in his life since he began this latest trip ...

IPF's effects are relentless, says columnist Charlene Marshall, who faced various knee surgery complications because of her lung disease.

Sam Kirton started his column in November 2021 and writes from his home at Lake Anna, Virginia, where he lives with his wife Susan. His diagnosis at age 59 with idiopathic pulmonary fibrosis in ...

Pulmonary Fibrosis Awareness Month may be coming to a close, but it's important to keep the momentum going, columnist Sam Kirton says.

Living with pulmonary fibrosis is already a daunting challenge, but when coupled with a sleep disorder like sleep apnea, the burden becomes even heavier. Sleep apnea, a condition in which breathing ...

Avalyn Pharma has started a Phase 2b clinical trial testing the safety and efficacy of AP01, its investigational inhaled formulation of pirfenidone, in adults with progressive pulmonary fibrosis (PF).

A University of Colorado professor has won the 2024 Alton Ochsner Award Relating Smoking and Disease for his work into how genetic and environmental factors, including smoking, contribute to a ...